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Introduction: Resection of left atrial appendage (LAA) during surgical ablation of atrial
ﬁbrillation may decrease the incidence of postoperative cerebrovascular events and increase
the induction and maintenance of sinus rhythm (SR). This study evaluates the effect of LAA
resection after the surgical ablation of atrial ﬁbrillation.
Materials and methods: A retrospective analysis was made of 599 patients who underwent
surgical myocardial revascularization and/or valve surgery with concomitant surgical abla-
tion of atrial ﬁbrillation. The LAA was resected in 140 patients and preserved in 459 patients.
Postoperative, 1-month and 1-year results were compared between the groups in terms of
TIA/CVA, maintenance of sinus rhythm, pacemaker dependence and mortality.
Results: The patients who underwent LAA resection were older, had more frequent persis-
tent AF and underwent more frequently biatrial ablation set. In this group, longer times of
extracorporeal circulation and longer cross-clamp times were observed. During the follow-
up period, the resection group has shown lower incidence of TIA/CVA and the overall
mortality was also lower in this group of patients.
Conclusion: The resection group in our study has shown the trend toward lower incidence of
TIA/CVA and statistically signiﬁcant decrease of overall mortality. This ﬁnding can support
routine LAA resection during surgical ablation of atrial ﬁbrillation.
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LAA plays an important role in human physiology. It is a
producer of atrial natriuretic peptide (ANP) in spite of the fact
that the production in right atrial appendage is 40 times
higher [1]. LAA has inﬂuence on induction of thirst [2] and
affects the relationship between pressure and blood volume,
and has the function of reservoir. Occlusion of the left atrial
appendage leads to an increase in pressure and volume in
the left atrium. It has positive effect on cardiac output [3,4],
although this effect was not conﬁrmed in elderly patients [5].
In patients with hypertension, LAAs were found bigger with
depressed ejection velocity [6]. In patients with long-term
atrial ﬁbrillation (AF) LAAs with higher volume were
identiﬁed as well as wall ﬁbrosis and reduction of musculi
pectinati.
LAA also plays an important role in pathogenesis of
thromboembolism (TE) in patients with AF. The risk of TE is
ﬁve times higher in patients with AF than without AF and the
source of emboli is in 90% in LAA [7] in case of non-valvular AF.
In actual guidelines of European Society of Cardiology, it is
clearly declared that TE can have an alternative source of
emboli to LAA in patients with AF, but the resection of LAA
during the MAZE procedure is fully authorized [8].
On this count there are a few clinical studies that compare
the clinical impact on LAA resection or preservation in terms
of sinus rhythm maintenance, TE events, pacemaker depen-
dence and mid-term mortality [9–11].
Materials and methods
Between January 2004 and December 2013, a total of 599
patients underwent cardiac surgery procedure with concomi-
tant surgical ablation of atrial ﬁbrillation at the Cardiac
Surgery Department of Hospital of České Budějovice, Czech
Republic. The decision to resect the LAA during the procedure
was inﬂuenced by several factors such as presence of
hypertension, diabetes mellitus, higher age, prevalent TE
event and type of AF (paroxysmal, persistent). The decision
was ﬁnally up to the attending surgeon and based on her/his
view and experiences in LAA resection.
Surgical technique
A median sternotomy approach was regularly used in all
patients and all procedures were performed on cardiopulmo-
nary bypass. For the ablation of AF Cardioblate CryoFlex
Surgical Ablation Probe (Medtronic, Minneapolis, USA) was
used. In the beginning of the reported period, the left-sided
ablation procedure was performed in patients with paroxys-
mal AF. It consisted of both-sided pulmonary veins isolation
and possible LAA resection. The bilateral ablation procedure
was performed in patients with persistent AF and in the latest
period also for patients with paroxysmal AF. It consisted of
bilateral vein isolation, as well as upper and lower box lesion
that connected opposite pulmonary veins and lesion from
lower box lesion to mitral isthmus. The bilateral ablation was
ﬁnished with a right sided lesion set which consisted of anintercaval lesion and an isthmus line connecting the inferior
vena cava with the cavotricuspidal isthmus.
Follow-up
All patients were monitored during the postoperative period
with Holter monitoring till the discharge from the hospital. They
were routinely administered warfarin for minimally 3 months
postoperatively, with a target range of international normalized
ration from 2 to 3. Patients who presented with AF events during
the hospitalization, patients who underwent electrical cardio-
version or patients with continuing AF at the discharge from
hospital were given amiodarone for 1-month period.
Follow-up rhythm monitoring was performed with 24-h
Holter monitoring at 1, 3, 6 and 12 months after the surgery
and patients had a medical examination from the attending
physician. AF events were deﬁned as any AF episodes during
the Holter monitoring that were recorded after the healing
period (3 months after the surgery). Any symptoms suggestive
of neurologic deﬁcit were evaluated by attending neurologist
and examined with imaging studies.
Statistical analysis
The obtained data set was evaluated using the following
statistical parameters: medians (MD) with ranges or as means
(M) with standard deviation (SD). The normal distribution was
tested by the D'Agostino–Pearson omnibus K2 tests and with
the Shapiro–Wilk normality test.
The non-parametric Mann–Whitney test was used for
comparing and studying the relationships between the
continuous variables. Moreover, Fischer's exact test was used
for comparing the categorical variables. A conﬁdence level of
95% was accepted as signiﬁcant.
The statistical analysis was performed with MS Excel 2003 for
Windows XP and the statistical analysis system GraphPad Prism
version 5.01 (Graph-Pad Software, Inc., San Diego, CA, USA).
Results
The preoperative characteristics of the patients are listed in
Table 1. The patients who underwent resection of the LAA were
older than those who underwent LAA preservation (71.0  7.0
vs. 69.1  7.6 years). The group of patients who underwent LAA
preservation had higher percentage of paroxysmal AF (45.3%);
on the other hand the group of patients who underwent LAA
resection had higher percentage of persistent AF (70.1%). These
differences were found to be statistically signiﬁcant. In the other
variables (gender, diabetes, hypertension, renal insufﬁciency,
preoperative TIA/CVA, COPD and ejection fraction) no differ-
ences reaching statistical signiﬁcance were found.
The perioperative characteristics of the patients are listed in
Table 2. The group of patients who underwent LAA resection had
longer times of extracorporeal circulation (108.3  38.2 vs. 99.7
 40.6 min) and aortic cross-clamp times (75.6  28.6 vs. 66.6
 32.3 min). The left sided ablation set was more common in
the preservation group (61.4%);otherwise the biatrial ablation set
was more common in the resection group (82.1%). The distribu-
tionof patients accordingto thetypeof surgeryislistedinTable2.
Fig. 2 – Incidence of post-operative pacemaker dependence
in resection and preservation groups.
Table 2 – Perioperative characteristics.
Characteristics Resection
group
Preservation
group
p value
Number of patients 140 459
CABG 49 (35) 145 (32)
CABG + valve procedure 38 (27) 121 (26)
Valve procedure 53 (38) 193 (42)
ECC time (min) 108.3  38.2 99.7  40.6 0.0179
Cx time (min) 75.6  28.6 66.6  32.3 0.0007
Left-sided ablation set 25 (17.9) 177 (38.6) <0.0001
Biatrial ablation set 115 (82.1) 282 (61.4) <0.0001
Data are n (%) or mean  SD, p-values ≤ 0.05 were considered
statistically signiﬁcant.
CABG, coronary artery bypass grafting; ECC, extracorporeal circula-
tion; Cx, aortic cross-clamp.
Table 1 – Preoperative characteristics.
Characteristics Resection
group
Preservation
group
p value
Number of patients 140 459
Age (years) 71.0  7.0 69.1  7.6 0.0069
Male 90 (64.3) 273 (59.5) 0.3245
Diabetes mellitus 49 (35.0) 161 (35.1) 1.00
Hypertension 123 (87.9) 358 (78.0) 0.2835
Renal insufﬁciency 14 (10.0) 69 (15.0) 0.1619
Preoperative TIA/CVA 19 (13.6) 38 (8.3) 0.0705
COPD 22 (15.7) 79 (17.2) 0.7966
Ejection fraction (%) 56.2  11.8 54.9  13.5 0.3512
Paroxysmal AF 36 (25.7) 208 (45.3) <0.0001
Persistent AF 99 (70.1) 231 (50.3) <0.0001
Data are n (%) or mean  SD, p-values ≤ 0.05 were considered
statistically signiﬁcant.
TIA, transitory ischemic attack; CVA, cerebrovascular accident;
COPD, chronic obstructive pulmonary disease; AF, atrial ﬁbrillation.
Fig. 3 – Incidence of post-operative sinus rhythm in
resection and preservation groups.
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were followed up: the incidence of transitory ischemic
attack/cerebrovascular event, the incidence and maintenance
of sinus rhythm, need of implantation of pacemaker and death.
Two out of these criteria reached the statistical signiﬁcance in 1-
year period – the lower incidence of sinus rhythm ( p < 0.0001)Fig. 1 – Incidence of post-operative TIA/CVA in resection
and preservation groups.and lower mortality ( p = 0.0008) in the resection group. The
distribution of these events is listed in Figs. 1–4.
Discussion
Resection of LAA during cardiac surgery leads to a signiﬁcant
reduction of thromboembolic risk. Although no randomized
trials are presented anywhere that demonstrate this
theory, we can ﬁnd several clinical trials. Cox et al. published
a study of 306 patients who underwent MAZE procedure with
excision of both atrial appendages. The postoperative stroke
rate was 0.7% and the stroke rate during 11 years of follow-up
was only 0.4% [12]. The study of Johnson et al. [13]
demonstrated that LAA removal brings a signiﬁcant stroke
risk reduction. On the other hand in their work, a higher
number of perioperative cerebrovascular events (4.8%) were
reported in the group of 435 patients. However, no new CVA
occurred and no LAA thrombus was detected during the
follow-up period. The fact that LAA removal/occlusion
decreases the incidence of CVA can be also found in a
Fig. 4 – Incidence of post-operative mortality in resection
and preservation groups.
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707 patients with AF randomized 2:1 between the device
(WATCHMAN) and warfarin. Nearly two thirds of the patients
had CHADS2 score of 1 or 2. After the WATCHMAN
implantation, there were 87% of patients who stopped
warfarin at 45 days post-implantation. Stroke event rate
was 2.6 patients-years in the WATCHMAN group versus 3.5
patients-years in the warfarin group [14]. That brings another
argument for LAA resection, particularly in patients with
long-standing AF. More than 20% of these patients stay in AF
after the MAZE procedure [15] and this appreciable number of
patients will stay in a high risk of CVA. Shirani and Alaeddini
reported that the LAA remodeling process (dilation, stretch-
ing, reduction in pectinate muscle, volume and endocardial
ﬁbroelastosis) in chronic AF patients persists after the
ablation in spite of successful AF intervention. This fact
provides additional justiﬁcation for routine LAA resection
whether or not successful AF ablation is achieved [16].
The resection of the LAA should be taken into consideration
also for the potential proarrhythmogenic role of LAA. In the
work of Di Biase et al. [17] patients who failed after catheter
ablation for AF underwent electrical mapping for trigger
location. In almost 30% of patients the trigger of AF was
found in LAA. A case report on the same topic was also
presented by Takahashi et al. [18]. In our report, we did not ﬁnd
any increase in the number of patients in the resection group
with sinus rhythm that was probably caused by higher
incidence of persistent AF in this group of patients.
Several techniques of interventional [19,20] and surgical
LAA exclusion are available, such as resection and use of a
stapler or ligation. Although the principle of these three
methods is same (to eliminate LAA from blood circuit) their
efﬁciency shows remarkable differences. Kanderian et al. [21]
have analyzed 137 patients after LAA resection, suture or
stapling. The criterion of successful LAA occlusion was: no LAA
communication under the suture or no LAA residue larger
than 1 cm on TEE examination. Only 73% resections, 23%
occlusions, and 0% staplers met the criteria. Gillinov et al. [22]
reported a study with a group of 222 patients with LAA
resection by using a stapler. Additional stitches due tobleeding under the stapler were required in 10% of patients,
and 2% of patients experienced periprocedural CVA. Katz et al.
[23] have demonstrated that endocardial suture can be
frequently insufﬁcient and is associated with residual leaks
which were identiﬁed in 36% patients in the group of patients.
For these reasons we ﬁnd LAA resection optimal for patients
undergoing MAZE procedure from conventional sternotomy.
This study is subject to the limitations inherent in
retrospective work with observational data. The non-random-
ized design may have affected the results owing to patients
selection bias. Other limitation can be found in shorter follow-
up period (1 year). The advantage of LAA resection may by
strengthened by longer follow-up. That would require pro-
spective designs with long-term follow-up period (e.g. 5 years).
Conclusion
In our study, we had found the trend toward lower incidence
of TIA/CVA and statistically signiﬁcant decrease of overall
mortality in the resection group in 1-year follow-up period. In
the relationship with results of our study we can recommend
routine LAA resection during ablation of AF.
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